Web Exclusives

Iman Ahmed, PharmD, BCOP, recently discussed the evidence for what’s actually contributing to health inequities in hematologic malignancies, and how providers can mitigate these disparities.

Healthcare deserts are regions in the United States with limited access to healthcare providers and medicine, often contributing to poor health outcomes and healthcare inequities for residents of these communities.

Learn about how clinical research trials are revolutionizing radiotherapy, leading to advancements reshaping cancer care for better patient outcomes and experiences.

A coalition of more than 40 health insurers recently announced plans for prior authorization reform.

In a roundtable discussion hosted by HHS, health insurers pledged 6 key reforms they say are designed to cut red tape, accelerate care decisions, and enhance

The phase 3 S2302 Pragmatica-Lung study offers a new blueprint for cancer clinical trials, one that emphasizes simplification, inclusivity, and real-world applicability, according to Konstantin Dragnev, MD, of Dartmouth Cancer Center.

Paula Aristizabal, MD, MAS, a pediatric hematologist/oncologist at Rady Children’s Hospital-San Diego/associate professor at the University of California San Diego, and her research team developed a peer navigation intervention known as the Childhood Malignancy Peer Research Navigation (Comprendo) program. This program pairs trained parent navigators—individuals who have experienced similar challenges with their own children’s cancer care—with parents who are newer to the experience, with the intention to guide these families through the informed consent process for childhood cancer clinical trials.

n the US cohort, Black patients with HR-positive/HER2-negative mBC who underwent NGS testing were more likely to receive first-line chemotherapy, less likely to have PIK3CA mutations, and less likely to receive first-line CDK4/6 inhibitors compared with White patients.